Search
×
FR

Placeholder headline

This is just a placeholder headline

API STD 521: Guide for Pressure-relieving and Depressuring Systems – Edition 6

$

682

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 653: Tank Inspection, Repair, Alteration, and Reconstruction – Edition 4

$

507

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:19 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series-18: Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z246.2-14 – Emergency preparedness and response for petroleum and natural gas industry systems

$

596

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:22 – Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z731-09 (R2014) – Emergency Preparedness and Response

$

177

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:23 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:26 – Storage of Hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA B51:24 Boiler, Pressure Vessel, and Pressure Piping Code

$

389

BUY NOW

ISO 22442:2007

ISO 22442:2007 Medical devices utilizing animal tissues and their derivatives – Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents

CDN $251.00

SKU: 2f724e17fb91 Category:

Description

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

Edition

1

Published Date

2007-11-27

Status

PUBLISHED

Pages

22

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

Previous Editions

Can’t find what you are looking for?

Please contact us at: